Search - tctmd.com

Displaying 221 - 240 of 316

Sort: Relevancy | Date

Presentation THT 2026

Longitudinal ImmuKnow Monitoring One Year After Heart Transplant: Associations with Rejection, Infection, and Cardiac Allograft Vasculopathy 

Presenter: David Golombeck

March 02, 2026

Presentation THT 2026

Comparing risk of in-hospital mortality in patient with cardiogenic shock due to ACS or HF using CSWG-SCAI criteria

Presenter: Kiana Shivaee

March 02, 2026

Presentation THT 2026

Engineering the Future: Human-AI Interfaces in Heart Failure Devices

Presenter: Ilan Richter

March 02, 2026

Presentation THT 2026

Implantation of iPS Cells Differentiated into Cardiomyocytes to Repair the Damaged Myocardium

Presenter: Eugene Jiaxian Wang

March 02, 2026

Presentation THT 2026

Comparing Predictors of Readmission in LVAD Patients Bridged to Transplant: Psoas Muscle Index versus Pre-Albumin

Presenter: Matthew Ramm

March 02, 2026

Presentation THT 2026

Hemodynamic TEE for Integrated Multimodal Assessment of RV Function: A Prospective Feasibility Study

Presenter: Ahmed Aburahma

March 02, 2026

Presentation THT 2026

AI in the Trenches: Lessons From Clinical Trial Optimization

Presenter: Jonathan Cunningham

March 02, 2026

Presentation THT 2026

Heart Transplantation in Adults Over 70 Years: National Trends and Center-Level Variability

Presenter: Dena E. Hayes

March 02, 2026

Presentation THT 2026

Cardiac Reprogramming Cocktail Delivered in a Single Adeno-Associated Virus to Improve Function in a Porcine Model of Ischemic Heart Failure

Presenter: Kathy Ivey

March 02, 2026

Presentation THT 2026

Intraaortic Balloon Pump in Cardiogenic Shock: Did We Rush to Bury It?

Presenter: Maya Guglin

March 02, 2026

Presentation THT 2026

Risk Redefined: Predictive Modeling and the AI-enabled HF Clinic

Presenter: Tariq Ahmad

March 02, 2026

Presentation THT 2026

Inducing Cardiomyocyte Proliferation Using Native Cell Cycle Pathways to Create More Cardiomyocytes

Presenter: James F. Martin

March 02, 2026

Presentation THT 2026

Characterizing Hemodynamic Phenotypes In Patients Not Meeting Diagnostic Criteria for Primary Graft Dysfunction

Presenter: Caroline Magro

March 02, 2026

Presentation THT 2026

Adjunctive Supersaturated Oxygen Therapy Following PCI in Acute Coronary Syndrome With Cardiogenic Shock: A Randomized Study

Presenter: Sanchit Kundal

March 02, 2026

Presentation THT 2026

Treating Danon Disease with Gene Therapy: Lessons Learned and Prospects for the Future

Presenter: Eric D. Adler

March 02, 2026

Presentation THT 2026

Characterizing the Untapped Pool of HIV+ Donors for Heart Transplantation

Presenter: Neha Parvathala

March 02, 2026

Presentation THT 2026

SHOCK-PRECISION: Early Phenotype-Guided Mechanical Circulatory Support in Cardiogenic Shock

Presenter: Juliana Giorgi

March 02, 2026

Presentation THT 2026

Beyond the Stethoscope: AI in HF Diagnosis and Phenotyping

Presenter: Heidi S. Hartman

March 02, 2026

Presentation THT 2026

Artificial Intelligence: Framing the Future of HF Diagnostics and Clinical Decision Making

Presenter: Anuradha (Anu) Lala-Trindade (Lala)

March 02, 2026

Presentation THT 2026

PARACHUTE-PCI: An adaptive, sham-controlled, simultaneous crossover trial of microaxial flow pumps to prevent cardiogenic shock during high risk PCI

Presenter: Pankaj Jain

March 02, 2026

Advertisement

Longitudinal ImmuKnow Monitoring One Year After Heart Transplant: Associations with Rejection, Infection, and Cardiac Allograft Vasculopathy

Comparing risk of in-hospital mortality in patient with cardiogenic shock due to ACS or HF using CSWG-SCAI criteria

Engineering the Future: Human-AI Interfaces in Heart Failure Devices

Implantation of iPS Cells Differentiated into Cardiomyocytes to Repair the Damaged Myocardium

Comparing Predictors of Readmission in LVAD Patients Bridged to Transplant: Psoas Muscle Index versus Pre-Albumin

Hemodynamic TEE for Integrated Multimodal Assessment of RV Function: A Prospective Feasibility Study

AI in the Trenches: Lessons From Clinical Trial Optimization

Heart Transplantation in Adults Over 70 Years: National Trends and Center-Level Variability

Cardiac Reprogramming Cocktail Delivered in a Single Adeno-Associated Virus to Improve Function in a Porcine Model of Ischemic Heart Failure

Intraaortic Balloon Pump in Cardiogenic Shock: Did We Rush to Bury It?

Risk Redefined: Predictive Modeling and the AI-enabled HF Clinic

Inducing Cardiomyocyte Proliferation Using Native Cell Cycle Pathways to Create More Cardiomyocytes

Characterizing Hemodynamic Phenotypes In Patients Not Meeting Diagnostic Criteria for Primary Graft Dysfunction

Adjunctive Supersaturated Oxygen Therapy Following PCI in Acute Coronary Syndrome With Cardiogenic Shock: A Randomized Study

Treating Danon Disease with Gene Therapy: Lessons Learned and Prospects for the Future

Characterizing the Untapped Pool of HIV+ Donors for Heart Transplantation

SHOCK-PRECISION: Early Phenotype-Guided Mechanical Circulatory Support in Cardiogenic Shock

Beyond the Stethoscope: AI in HF Diagnosis and Phenotyping

Artificial Intelligence: Framing the Future of HF Diagnostics and Clinical Decision Making

PARACHUTE-PCI: An adaptive, sham-controlled, simultaneous crossover trial of microaxial flow pumps to prevent cardiogenic shock during high risk PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content